Vinorelbine and skin toxicity Patient Reports March 20, 2010

Vinorelbine Side Effects Report #4924602-9
Vinorelbine side effect was reported by a Physician from SPAIN on Feb 10, 2006. Female patient was diagnosed with breast cancer metastatic and was treated with Vinorelbine. After drug was administered, patient experienced the following side effects: skin toxicity. Vinorelbine dosage: 30 MG/M** 2; IV. Patient recovered.

Vinorelbine Side Effects Report #4924606-6
Vinorelbine side effect was reported by a Physician from SPAIN on Feb 10, 2006. Female patient was diagnosed with breast cancer metastatic and was treated with Vinorelbine. After drug was administered, patient experienced the following side effects: haematotoxicity, skin toxicity. Vinorelbine dosage: 35 MG/M**2; IV. Patient recovered.

Vinorelbine Side Effects Report #4948469-8
Vinorelbine side effect was reported by a Physician from SPAIN on Feb 10, 2006. Female patient was diagnosed with breast cancer metastatic and was treated with Vinorelbine. After drug was administered, patient experienced the following side effects: skin toxicity. Vinorelbine dosage: 30 MG/M**2; IV. During the same period patient was treated with PEGYLATED LIPOSOMAL DOXORUBICIN. Patient recovered.

Vinorelbine Side Effects Report #4948472-8
Vinorelbine side effect was reported by a Physician from SPAIN on Feb 10, 2006. Female patient was diagnosed with breast cancer metastatic and was treated with Vinorelbine. After drug was administered, patient experienced the following side effects: skin toxicity. Vinorelbine dosage: 35 MG/M**2; IV. During the same period patient was treated with PEGYLATED LIPOSOMAL DOXORUBICIN. Patient recovered.